- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06173141
Effect of Intradialytic Continuous Versus Interval Aerobic Exercises on Functional Capacity in Patients With Chronic Renal Failure.
Effect of Intradialytic Continuous Versus Interval Aerobic Exercises on Functional Capacity Quality of Life and in Patients With Chronic Renal Failure.
Chronic kidney disease has emerged as one of the leading causes of mortality worldwide, and it is one of a small number of non-communicable diseases that have shown an increase in associated deaths over the past 2 decades. The high number of affected individuals and the significant adverse impact of chronic kidney disease should prompt enhanced efforts for better prevention and treatment.
Chronic kidney disease is a serious medical problem, as it is associated with high risks of complications which lead to poor quality of life and physical capacity.
Study Overview
Status
Conditions
Detailed Description
Sixty-seven patients undergoing haemodialysis randomly be allocated into three groups, (A, B & C). Group A (low- to moderate-continuous intensity cycling exercises, group B (moderate- to high-interval intensity cycling exercises), the exercises performed two sessions per week for two months and group (C)Twenty three patients received the hemodialysis sessions only.
Group A (low- to moderate-continuous intensity cycling exercises:
Twenty three patients performed aerobic exercise during dialysis using Pedal machine at low- to moderate continuous intensity rating from 11 to 13 on the Borg scale for 15-30 minutes.
warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities.
Group B (moderate- to high-interval intensity cycling exercises), Twenty one patients performed aerobic exercise during dialysis using Pedal machine at moderate-to-high interval intensity rating from 12 to 15 on the Borg scale for 15-30 minutes.
warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities.
Inclusion Criteria:
- Sixty seven patients of both sexes
- Age will range from 35-55 years old.
- BMI will be from 25-34.5 Kg/m2.
- All patients with stage 5 of CRF.
- All patients are stable on dialysis for at least six months before the study.
- Stable medical and clinical hemodynamic state.
Exclusion criteria:
- Patients with hearing impairment or mental disorder.
- Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
- Patients with auto-immune diseases.
- Chronic inflammatory orthopedic disorders and rheumatoid arthritis.
- Patients with history of neuromuscular disease (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).
- Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
- Patients with BMI > 35Kg/m2.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt, 11517
- Faculty of physical therapy - Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Sixty-seven patients of both sexes
- Age will range from 35-55 years old.
- BMI will be from 25-34.5 Kg/m2.
- All patients with stage 5 of CRF.
- All patients are stable on dialysis for at least six months before the study.
- Stable medical and clinical hemodynamic state.
Exclusion Criteria:
1. Patients with hearing impairment or mental disorder. 2. Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
3. Patients with auto-immune diseases. 4. Chronic inflammatory orthopedic disorders and rheumatoid arthritis. 5. Patients with history of neuromuscular disease (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).
6. Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
7. Patients with BMI > 35Kg/m2.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group A (low- to moderate-continuous intensity cycling exercises:
Patients performed aerobic exercise during dialysis using Pedal machine at low- to moderate continuous intensity rating from 11 to 13 on the Borg scale for 15-30 minutes. warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities |
aerobic exercise during dialysis using Pedal machine at low- to moderate continuous intensity rating from 11 to 13 on the Borg scale for 15-30 minutes. warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities
Other Names:
|
|
Active Comparator: Group B (moderate- to high-interval intensity cycling exercises),
Patients performed aerobic exercise during dialysis using Pedal machine at moderate-to-high interval intensity rating from 12 to 15 on the Borg scale for 15-30 minutes. warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities |
aerobic exercise during dialysis using Pedal machine at moderate-to-high interval intensity rating from 12 to 15 on the Borg scale for 15-30 minutes. warming up and cool down (approximately 10 minutes) in form of free active exercise of the lower extremities |
|
Sham Comparator: group (C)
received the hemodialysis sessions only.
|
hemodialysis sessions only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kidney Disease Quality of Life Questionnaire -SF36(KDQoL-SF36)
Time Frame: pre and post treatment after 2 months
|
The KDQOL™-36 contains 5 subscales: The Physical Component Summary (PCS), Mental Component Summary (MCS), Burden of Kidney Disease (BKD), Symptoms and Problems of Kidney Disease (SPKD), and Effects of Kidney Disease (EKD).
The first 2 subscales are a generic measure of HRQOL (and are identical to the SF-12), whereas the last 3 assess issues specific to patients with ESRD or earlier stages of chronic kidney disease.
|
pre and post treatment after 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
blood urea, serum creatinine
Time Frame: pre and post treatment after 2 months
|
Blood samples are drawn from the arterial side of the hemodialysis access immediately prior to hemodialysis.
Blood sample must be drawn before dialysis is started to prevent this sample from reflecting any impact of dialysis.
pre and post kitz blood samples were sent to benha university hospital laboratory for estimating blood urea and creatinine.
|
pre and post treatment after 2 months
|
|
6-min walk distance
Time Frame: pre and post treatment after 2 months
|
6min walk test carried out before and after the intervention to determine patient physical functional capacity.
According to the American Thoracic Society ,Guidelines for the Six-Minute Walk Test (ATS .2002).
|
pre and post treatment after 2 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Pei G, Tang Y, Tan L, Tan J, Ge L, Qin W. Aerobic exercise in adults with chronic kidney disease (CKD): a meta-analysis. Int Urol Nephrol. 2019 Oct;51(10):1787-1795. doi: 10.1007/s11255-019-02234-x. Epub 2019 Jul 22.
- Wulczyn KE, Zhao SH, Rhee EP, Kalim S, Shafi T. Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol. 2022 Apr;17(4):496-506. doi: 10.2215/CJN.13010921. Epub 2022 Mar 4.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Chronic renal failure
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
-
Benha UniversityCompletedChronic Kidney Diseases | Chronic Kidney Disease 5DEgypt
Clinical Trials on low- to moderate-continuous intensity cycling exercises:
-
Ohio UniversityAmerican Heart AssociationSuspendedSarcopenia | Aging | Disability PhysicalUnited States
-
Western University, CanadaCompleted
-
Foundation University IslamabadRecruiting
-
Liye ZouNot yet recruiting
-
Universiti Sains MalaysiaNot yet recruitingType 2 Diabetes Mellitus (T2DM)Malaysia
-
Shenzhen UniversityNot yet recruiting
-
University of Alabama at BirminghamNot yet recruitingAging | Cognitive Decline | Neuroplasticity | Stroke, Chronic | Motor DysfunctionUnited States
-
Riphah International UniversityCompletedOverweight and ObesityPakistan
-
University of Colorado, BoulderCompleted
-
Universitat de GironaUniversity Hospital of Girona Dr. Josep TruetaActive, not recruitingType 1 Diabetes (T1D)Spain